Properties: Gray or white flakes or powder. pI 3.9. Sol in water, physiol saline soln, in pyridine. Practically insol in alcohol, ether, acetone, benzene. Deteriorates on storage in sealed ampuls, on exposure to heat and when in soln with dil acids.
Derivative Type: Desirudin
CAS Registry Number: 120993-53-5
CAS Name: 63-Desulfohirudin (Hirudo medicinalis isoform HV1)
Additional Names: ds-hirudinTrademarks: Revasc (Aventis)
Literature References: Identical in amino acid sequence to natural hirudin variant 1 (HV1) except that it lacks a sulfate group on Tyr at residue 63. Production by recombinant DNA technology: M. Liersch et al.,
EP
168342 (1986 to Ciba-Geigy); eidem,
US
5422249 (1995 to Ciba-Geigy; UCP Gen-Pharma); E. Fortkamp et al., DNA
5, 511 (1986); J. Dodt et al., FEBS Lett.
202, 373 (1986). Physicochemical properties: A. Electricwala et al., Thromb. Haemostasis
63, 499 (1990). Clinical pharmacology: M. Verstraete et al., J. Am. Coll. Cardiol.
22, 1080 (1993). Clinical trial in coronary angioplasty: A. A. van den Bos et al., Circulation
88, 2058 (1993); in acute coronary syndromes: E. J. Topol et al., N. Engl. J. Med.
335, 775 (1996).
Derivative Type: Lepirudin
CAS Registry Number: 138068-37-8
CAS Name: 1-L-Leucine-2-L-threonine-63-desulfohirudin (Hirudo medicinalis isoform HV1)Trademarks: Refludan (Aventis)
Literature References: Peptide of 65 amino acids produced by recombinant DNA technology. Prepn: P. Crause et al.,
EP
324712; eidem,
US
5180668 (1989, 1993 both to Hoechst AG). Clinical pharmacology: H. J. Roethig et al., Int. Congr. Ser. - Excerpta Med.
944, 227 (1991). Clinical trial as adjunctive therapy with TPA: U. Zeymer et al., Am. J. Cardiol.
76, 997 (1995); in heparin-induced thrombocytopenia: F. Schiele et al., Am. J. Hematol.
50, 20 (1995).
Therap-Cat: Antithrombotic.
Keywords: Anticoagulant.
产品链接: 8001-27-2››